Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-02-06
1994-03-22
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514306, 514314, 514317, 514318, 514323, 514326, 514415, 514419, A61K 31445
Patent
active
052964795
ABSTRACT:
There are provided cycloalkyl piperidine compounds which are useful in the treatment of physiological or drug-induced psychosis or dyskinesia in a mammal. These novel compounds are selective sigma receptor antagonists and have a low potential for movement disorder side effects associated with typical antipsychotic agents.
REFERENCES:
patent: 4294841 (1981-10-01), Champsiex et al.
CA95:24830h, Eistetter et al, 1981.
J. Med. Chem. 15(6), Irwin et al, pp. 690-692, 1972.
CA96:123074s, Trijzelaar et al, 1982.
Cain Gary A.
Gilligan Paul J.
Tam Sang W.
Ferguson Blair Q.
Horn Margaret A.
Ivy C. Warren
The Du Pont Merck Pharmaceutical Company
Trinh Ba K.
LandOfFree
Treatment of psychosis using 1-cycloalkylpiperidines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of psychosis using 1-cycloalkylpiperidines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of psychosis using 1-cycloalkylpiperidines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-437233